Vertex, BMS to test hepatitis C combo
This article was originally published in Scrip
Executive Summary
Vertex Pharmaceuticals and Bristol-Myers Squibb have entered into a collaboration to test their experimental hepatitis C drugs together, another example that some companies need to partner to find the best combination for next-generation treatments of the virus.